AstraZeneca India gets CDSCO approval for additional indication for Osimertinib in unresectable EGFR-mutated lung cancer Read more
AstraZeneca’s Trastuzumab deruxtecan therapy receives CDSCO nod to manage HER2- low & ultra-low breast cancer in India Read more
Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes Read more
FOPE & PharmaState Academy conducts session 17 on gap analysis and implementation plan for Revised Schedule M Read more
AstraZeneca gains CDSCO approval to import SZC for treating Hyperkalaemia in adult patients Read more